BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35908832)

  • 1. Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades.
    Boele FW; den Otter PWM; Reijneveld JC; de Witt Hamer PC; van Thuijl HF; Lorenz LMC; Wesseling P; Lagerwaard FJ; Taphoorn MJB; Kouwenhoven MCM; Snijders TJ; Douw L; Klein M
    Neuro Oncol; 2023 Feb; 25(2):351-364. PubMed ID: 35908832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in stable, long-term survivors of low-grade glioma.
    Boele FW; Douw L; Reijneveld JC; Robben R; Taphoorn MJ; Aaronson NK; Heimans JJ; Klein M
    J Clin Oncol; 2015 Mar; 33(9):1023-9. PubMed ID: 25667287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life after surgical resection of a low-grade glioma: A prospective cross-sectional study evaluating health-related quality of life.
    Teng KX; Price B; Joshi S; Alukaidey L; Shehab A; Mansour K; Toor GS; Angliss R; Drummond K
    J Clin Neurosci; 2021 Jun; 88():259-267. PubMed ID: 33992194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial.
    Boele FW; Klein M; Verdonck-de Leeuw IM; Cuijpers P; Heimans JJ; Snijders TJ; Vos M; Bosma I; Tijssen CC; Reijneveld JC;
    J Neurooncol; 2018 Mar; 137(1):191-203. PubMed ID: 29236238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing quality of life and mastery of informal caregivers of high-grade glioma patients: a randomized controlled trial.
    Boele FW; Hoeben W; Hilverda K; Lenting J; Calis AL; Sizoo EM; Collette EH; Heimans JJ; Taphoorn MJ; Reijneveld JC; Klein M
    J Neurooncol; 2013 Feb; 111(3):303-11. PubMed ID: 23212677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033.
    Dirven L; Reijneveld JC; Taphoorn MJB; Coens C; El-Badawy SA; Tzuk-Shina T; Bravo-Marques J; Back M; Stalpers LJA; Stupp R; Baumert BG; Seidel C
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):90-100. PubMed ID: 30716525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life of long-term high-grade glioma survivors.
    Bosma I; Reijneveld JC; Douw L; Vos MJ; Postma TJ; Aaronson NK; Muller M; Vandertop WP; Slotman BJ; Taphoorn MJ; Heimans JJ; Klein M
    Neuro Oncol; 2009 Feb; 11(1):51-8. PubMed ID: 18617599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition.
    Geens W; Vanlaer N; Nijland L; Van Laere S; Schwarze JK; Bruneau M; Neyns B; Rogiers A; Duerinck J
    J Neurooncol; 2024 May; 168(1):159-169. PubMed ID: 38502281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in glioma patients in China.
    Cheng JX; Liu BL; Zhang X; Lin W; Zhang YQ; Liu WP; Zhang JN; Lin H; Wang R; Yin H
    BMC Cancer; 2010 Jun; 10():305. PubMed ID: 20565883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial.
    Boele FW; Douw L; de Groot M; van Thuijl HF; Cleijne W; Heimans JJ; Taphoorn MJ; Reijneveld JC; Klein M
    Neuro Oncol; 2013 Oct; 15(10):1420-8. PubMed ID: 23925452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue in low-grade glioma.
    Struik K; Klein M; Heimans JJ; Gielissen MF; Bleijenberg G; Taphoorn MJ; Reijneveld JC; Postma TJ
    J Neurooncol; 2009 Mar; 92(1):73-8. PubMed ID: 19066729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term health-related quality of life and neurocognitive functioning after treatment in skull base meningioma patients.
    Fisher FL; Zamanipoor Najafabadi AH; van der Meer PB; Boele FW; Peerdeman SM; Peul WC; Taphoorn MJB; Dirven L; van Furth WR
    J Neurosurg; 2022 Apr; 136(4):1077-1089. PubMed ID: 34598137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognition and health-related quality of life in long-term survivors of high-grade glioma: an interactive perspective from patient and caregiver.
    Spoor JKH; Donders-Kamphuis M; Veenstra WS; van Dijk SA; Dirven CMF; Sillevis Smitt PAE; van den Bent MJ; Leenstra S; Satoer DD
    Acta Neurochir (Wien); 2024 Apr; 166(1):166. PubMed ID: 38565800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: a comparative study.
    Boele FW; Heimans JJ; Aaronson NK; Taphoorn MJ; Postma TJ; Reijneveld JC; Klein M
    J Neurooncol; 2013 Oct; 115(1):87-94. PubMed ID: 23824535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy.
    van der Meer PB; Habets EJJ; Wiggenraad RG; Verbeek-de Kanter A; Lycklama À Nijeholt GJ; Zwinkels H; Klein M; Dirven L; Taphoorn MJB
    J Neurooncol; 2018 Sep; 139(2):359-368. PubMed ID: 29663172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma: Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials.
    Caramanna I; Bottomley A; Drijver AJ; Twisk J; van den Bent M; Idbaih A; Wick W; Pe M; Klein M; Reijneveld JC;
    Eur J Cancer; 2021 Feb; 144():162-168. PubMed ID: 33348088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma.
    Noll KR; Bradshaw ME; Weinberg JS; Wefel JS
    Psychooncology; 2017 May; 26(5):617-624. PubMed ID: 26677053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom networks in glioma patients: understanding the multidimensionality of symptoms and quality of life.
    Röttgering JG; Varkevisser TMCK; Gorter M; Belgers V; De Witt Hamer PC; Reijneveld JC; Klein M; Blanken TF; Douw L
    J Cancer Surviv; 2024 Jun; 18(3):1032-1041. PubMed ID: 36922442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting.
    Hickmann AK; Hechtner M; Nadji-Ohl M; Janko M; Reuter AK; Kohlmann K; Haug M; Grüninger S; Deininger M; Ganslandt O; König J; Wirtz CR; Coburger J; Renovanz M
    J Neurooncol; 2017 Jan; 131(1):135-151. PubMed ID: 27638638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment.
    van Kessel E; Baumfalk AE; van Zandvoort MJE; Robe PA; Snijders TJ
    J Neurooncol; 2017 Aug; 134(1):9-18. PubMed ID: 28567586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.